Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 3Breast 3Gastrointestinal 2Other solid neoplasm 1Lymphoid 1Gynecologic 1CNS 1

Conditions

Fasting in Malignant Solid Tumors 1

Interventions

Cisplatin 60Carboplatin 55Cyclophosphamide 47Pemetrexed 45Irinotecan 33pembrolizumab 32Paclitaxel 29Etoposide 29Gemcitabine 28Nivolumab 24Bevacizumab 24Interviews as Topic 23Vincristine 22Capecitabine 22Topotecan 20Filgrastim 20Early Intervention, Educational 20fludarabine 19Oxaliplatin 19Docetaxel 19Specimen Handling 18Drug Therapy 18Temozolomide 17Sorafenib 17Leucovorin 17Everolimus 17Educational Status 17Radiotherapy 16Methods 16Fluorouracil 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Angptl4 protein, mouse × Other solid neoplasm × Clear all
NCT00936364 2025-06-02

Short-Term Fasting: Impact on Toxicity

University of Southern California

Phase NA Terminated
47 enrolled
Other solid neoplasm

Fasting in Malignant Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡